Thomson Reuters Corp Enters Oversold Territory

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100. A stock is considered to be oversold if the RSI reading falls below 30.

In trading on Thursday, shares of Thomson Reuters Corp ( TRI) entered into oversold territory, hitting an RSI reading of 26.8, after changing hands as low as $35.35 per share. By comparison, the current RSI reading of the S&P 500 ETF (SPY) is 48.1. A bullish investor could look at TRI's 26.8 RSI reading today as a sign that the recent heavy selling is in the process of exhausting itself, and begin to look for entry point opportunities on the buy side. The chart below shows the one year performance of TRI shares:

START SLIDESHOW:
Find out what 9 other oversold stocks you need to know about »

Thomson Reuters Corp 1 Year Performance Chart

Looking at the chart above, TRI's low point in its 52 week range is $33.21 per share, with $38.73 as the 52 week high point — that compares with a last trade of $36.14.

According to the ETF Finder at ETF Channel, TRI makes up 1.92% of the SuperDividend U.S. ETF ( DIV) which is trading lower by about 0.7% on the day Thursday.

If you liked this article you might like

Dow Tumbles 362 Points; S&P 500 and Nasdaq Also Finish Lower

Dow Tumbles 362 Points; S&P 500 and Nasdaq Also Finish Lower

Dow Selloff, Thomson Reuters, Jamie Dimon, Exxon, Waymo - 5 Things You Must Know

Dow Selloff, Thomson Reuters, Jamie Dimon, Exxon, Waymo - 5 Things You Must Know

Janet Yellen's Swan Song and Everything Else You Need to Know Tuesday Morning

Janet Yellen's Swan Song and Everything Else You Need to Know Tuesday Morning

Thomson Reuters in Talks With Blackstone to Sell Unit Stake Worth $17 Billion

Thomson Reuters in Talks With Blackstone to Sell Unit Stake Worth $17 Billion

Cara Therapeutics, Thomson Reuters, Wynn Resorts: 'Mad Money' Lightning Round

Cara Therapeutics, Thomson Reuters, Wynn Resorts: 'Mad Money' Lightning Round